Researchers have presented new findings related to lung cancer at the European Society for Medical Oncology (ESMO) conference in Barcelona, Spain. These new findings by Yale Cancer Center scientists have found that higher levels of genetic mutations in a tumor are linked to improved clinical outcomes to treat non-small cell lung cancer. According to this